Principal Financial Group
COLL icon

Principal Financial Group’s Collegium Pharmaceutical COLL Stock Holding History

Principal Financial Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.1M Buy
1,632,360
+337,332
+26% +$11.5M 0.03% 465
2026
Q1 		$42.8M Sell
1,295,028
-18,634
-1% -$789K 0.02% 533
2025
Q4 		$60.8M Buy
1,313,662
+3,891
+0.3% +$163K 0.03% 411
2025
Q3 		$45.8M Sell
1,309,771
-157,104
-11% -$5.46M 0.02% 494
2025
Q2 		$43.4M Sell
1,466,875
-106,481
-7% -$3.04M 0.02% 508
2025
Q1 		$47M Sell
1,573,356
-71,695
-4% -$2.19M 0.03% 461
2024
Q4 		$47.1M Sell
1,645,051
-100,767
-6% -$3.33M 0.03% 480
2024
Q3 		$67.5M Buy
1,745,818
+64,958
+4% +$2.32M 0.04% 382
2024
Q2 		$54.1M Buy
1,680,860
+128,003
+8% +$4.44M 0.03% 430
2024
Q1 		$60.3M Sell
1,552,857
-16,294
-1% -$570K 0.04% 417
2023
Q4 		$48.3M Sell
1,569,151
-10,089
-0.6% -$253K 0.03% 456
2023
Q3 		$35.3M Sell
1,579,240
-4,053
-0.3% -$92.4K 0.03% 524
2023
Q2 		$34M Buy
1,583,293
+32,255
+2% +$732K 0.02% 566
2023
Q1 		$37.2M Sell
1,551,038
-120,029
-7% -$3.18M 0.03% 524
2022
Q4 		$38.8M Sell
1,671,067
-91,533
-5% -$1.85M 0.03% 493
2022
Q3 		$28.2M Buy
1,762,600
+24,309
+1% +$429K 0.02% 570
2022
Q2 		$30.8M Buy
1,738,291
+320,778
+23% +$5.4M 0.02% 571
2022
Q1 		$28.9M Buy
1,417,513
+111,770
+9% +$2.11M 0.02% 689
2021
Q4 		$24.4M Buy
1,305,743
+248,132
+23% +$4.84M 0.01% 808
2021
Q3 		$20.9M Buy
1,057,611
+25,684
+2% +$555K 0.01% 911
2021
Q2 		$24.4M Buy
1,031,927
+323,854
+46% +$7.48M 0.02% 811
2021
Q1 		$16.8M Buy
708,073
+333,737
+89% +$7.93M 0.01% 1065
2020
Q4 		$7.5M Buy
+374,336
New +$7.31M 0.01% 1383

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Principal Financial Group's COLL Position: Q2 2026 in Review

Principal Financial Group increased its Collegium Pharmaceutical (COLL) stake by 26% in Q2 2026, buying an estimated $11.5M and bringing the position to 1,632,360 shares worth $59.1M. The position accounts for 0.03% of the portfolio, ranked #465.

Principal Financial Group first reported a position in COLL in Q4 2020 and has held it in 23 quarters since. The position peaked at $67.5M in Q3 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Principal Financial Group held 1,632,360 shares of Collegium Pharmaceutical worth $59.1M as of Q2 2026.
  • Principal Financial Group bought 337,332 Collegium Pharmaceutical shares in Q2 2026, an estimated $11.5M.
  • Collegium Pharmaceutical made up 0.03% of Principal Financial Group's portfolio in Q2 2026, its #465 holding.
  • Principal Financial Group first reported a position in Collegium Pharmaceutical in Q4 2020 and has held it in 23 quarters since.
  • Principal Financial Group's Collegium Pharmaceutical position peaked at $67.5M in Q3 2024.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.